Analysis of the role of GSK3 in the mitotic checkpoint

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Biology

Background:

• The mitotic checkpoint is crucial for accurate chromosome segregation, preventing aneuploidy, a common feature in cancer.
• Defects in the mitotic checkpoint lead to aneuploidy and are implicated in cancer development.
• The mitotic checkpoint complex (MCC), comprising Mad2, BubR1, Bub1, and Bub3, inhibits anaphase onset when chromosomes are unattached.

Purpose of the Study:

• To investigate the role of glycogen synthase kinase 3 (GSK3) in regulating the mitotic checkpoint.
• To explore the connection between GSK3 activity and growth-signaling pathways (WNT and PI3K/Akt) in mitotic arrest.

Main Methods:

• Utilized GSK3 inhibitors (SB 415286, RO 318220, lithium chloride) and genetic manipulation (knockout, RNAi) to assess GSK3's role.
• Examined the effect of GSK3 modulation on kinetochore localization of checkpoint proteins (Mad2, BubR1, Bub1) and MCC assembly.
• Investigated the impact of inhibiting WNT and PI3K/Akt signaling pathways on mitotic arrest duration.

Main Results:

• GSK3 activity is required for a robust mitotic checkpoint; its inhibition shortens spindle toxin-induced mitotic arrest.
• GSK3 is essential for the proper kinetochore localization of Mad2, BubR1, and Bub1, and for MCC assembly.
• Inhibition of WNT and PI3K/Akt signaling pathways enhances mitotic arrest in the presence of Taxol, indicating their negative regulation of GSK3.

Conclusions:

• GSK3 plays a critical role in maintaining the integrity and function of the mitotic checkpoint.
• The findings reveal a novel regulatory mechanism of the mitotic checkpoint involving GSK3 and its interplay with WNT and PI3K/Akt signaling pathways.
• This research provides new insights into how growth-signaling pathways can influence cell cycle progression and chromosome stability.